ClinicalTrials.gg
RecruitingNCT07383935Updated Feb 11, 2026

Stress Ball Use During Chemotherapy in Gastrointestinal Cancer Patients

An interventional study of Stress Ball in Gastrointestinal System Cancer, sponsored by Artvin Coruh University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by Artvin Coruh University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Gastrointestinal Neoplasms with a site in Turkey — 3 open to participants now, 5 under way, 1 of them phase 3. Gastrointestinal Neoplasms · Turkey.

Started
2026
with 2 others
No phase
4 of 21
1 open now
Registered
18th of 21
by date
Lead sponsor
1 of 21
Artvin Coruh University

Among the 21 studies in Gastrointestinal Neoplasms with a site in Turkey, this one is one of 3 that started in 2026, is one of 4 with no phase, and was the 18th registered.

Gastrointestinal Neoplasms

698 studies on the registry are indexed under Gastrointestinal Neoplasms; 211 are open to participants now.

Browse Gastrointestinal Neoplasms studies →

Open to participants now

3 of the 21 studies in Gastrointestinal Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 160 Gastrointestinal Neoplasms studies recruiting now, 121 (76%) set no upper age limit and 19 (12%) stop at 75 or younger; 8 take children under 18; 10 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Gastrointestinal Neoplasms with a site in Turkey, or all of them as a file.
02

Study summary

This study will investigate whether using a stress ball during chemotherapy can reduce anxiety, fear, and changes in vital signs in patients with gastrointestinal system cancers.

Patients receiving chemotherapy for gastrointestinal cancers often experience anxiety and fear, which may affect their heart rate, blood pressure, and breathing. A stress ball is a simple, low-cost, and safe method that may help patients relax during treatment.

In this randomized controlled study, 60 patients receiving chemotherapy will be assigned to either a stress ball group or a routine care group. Patients in the stress ball group will squeeze a stress ball for 15 minutes during their chemotherapy session. Anxiety, fear levels, and vital signs will be measured before and after chemotherapy in both groups.

The results of this study may help determine whether stress ball use is an effective non-drug method to improve emotional well-being and physiological stability in patients undergoing chemotherapy.

Read the detailed description

This study is a randomized controlled experimental trial designed to evaluate the effects of stress ball use during chemotherapy on anxiety, fear, and vital signs in patients with gastrointestinal system cancers.

Participants will be adult patients diagnosed with gastrointestinal system cancers who are receiving chemotherapy at the Artvin State Hospital Chemotherapy Unit. Eligible patients who provide informed consent will be randomly assigned in a 1:1 ratio to either an experimental group (stress ball intervention) or a control group (routine care).

Patients in the experimental group will be instructed to squeeze a medium-firm stress ball for 15 minutes starting at the beginning of their chemotherapy session. They will be guided to inhale while squeezing the ball and exhale while releasing it, focusing their attention on the activity. Patients in the control group will receive routine chemotherapy care without any additional intervention.

Anxiety and fear levels will be assessed before and after chemotherapy using validated measurement tools. Vital signs including blood pressure, heart rate, respiratory rate, body temperature, and oxygen saturation will also be recorded before and after the chemotherapy session. Outcomes will be compared between and within groups to determine the effectiveness of the stress ball intervention.

This study aims to provide evidence on whether a simple non-pharmacological method can improve psychological well-being and physiological stability during chemotherapy in patients with gastrointestinal system cancers.

03

Conditions studied

  • Gastrointestinal System Cancer
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being aged 18 years or older
  • Having a diagnosis of gastrointestinal system cancer and receiving chemotherapy
  • Having no communication problems
  • Having no physical disability that would prevent squeezing a stress ball
  • Willingness to participate in the study

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Stress Ball Intervention

    Participants in this arm will receive routine chemotherapy care and will additionally perform stress ball squeezing for 15 minutes starting at the beginning of the chemotherapy session. Patients will be instructed to inhale while squeezing the ball and exhale while releasing it, focusing attention on the activity.

    Behavioral: Stress Ball

  • No intervention
    Routine Care Control

    Participants in this arm will receive routine chemotherapy care during their chemotherapy session and will not perform any stress ball or additional relaxation intervention.

Interventions

  • BehavioralStress Ball

    The intervention consists of guided stress ball squeezing during chemotherapy. A round, medium-firm, compressible stress ball approximately 5-6 cm in diameter will be provided to participants. Starting at the beginning of the chemotherapy session, participants will squeeze the stress ball continuously for 15 minutes. They will be instructed to inhale while squeezing the ball, exhale while releasing their grip, and focus their attention on the squeezing activity. Disposable gloves will be used to maintain hygiene during the intervention. No additional behavioral or pharmacological interventions will be applied.

06

What researchers measure

Primary outcomes

  1. State Anxiety (STAI-State) score

    Time frame: Baseline (before chemotherapy session) and immediately after chemotherapy session

Secondary outcomes

  1. Fear Severity (VAS-Fear)

    Fear severity will be measured using a Visual Analog Scale (VAS-Fear). The change in scores before and after chemotherapy will be evaluated to assess the effect of the intervention on fear.

    Time frame: Baseline (before chemotherapy session) and immediately after chemotherapy session

  2. Systolic Blood Pressure

    Systolic blood pressure measured using an automatic sphygmomanometer.

    Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.

  3. Diastolic Blood Pressure

    Diastolic blood pressure measured using an automatic sphygmomanometer.

    Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.

  4. Heart Rate (Pulse)

    Heart rate measured in beats per minute using an pulse oximeter

    Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.

  5. Respiratory Rate

    Respiratory rate measured by counting chest movements for one minute.

    Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session

  6. Body Temperature

    Body temperature measured using a tympanic thermometer.

    Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.

  7. Oxygen Saturation (SpO₂)

    Time frame: Baseline (immediately before chemotherapy session) and immediately after completion of the chemotherapy session.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.

Of 154 non-industry interventional studies with no phase under Gastrointestinal Neoplasms, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 71. This study's planned 12 months is below that.

Counting every sponsor, half of 164 studies reached it within 36 months; a quarter within 17 and three quarters within 71.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 19, 2026
First posted
Feb 3, 2026
StartActual
Feb 3, 2026
Primary completionEst.
Feb 3, 2027
CompletionEst.
Feb 3, 2027
Last update
Feb 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07383935
Lead sponsor
Artvin Coruh University
Responsible party
EMRE ERKAL (The Effect of Stress Ball on Anxiety, Fear, and Vital Signs in Patients With Gastrointestinal System Cancer, Artvin Coruh University) — Principal investigator
First posted
Feb 3, 2026
Start date
Feb 3, 2026
Primary completion
Feb 3, 2027 (estimated)
Completion
Feb 3, 2027 (estimated)
Last update
Feb 11, 2026

Study contacts

Efe Hasdemir Efe Hasdemir, MD
Contact
hasdemir52@gmail.com
+90 5433750709

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion